TESARO INC's ticker is TSRO and the CUSIP is 881569107. A total of 142 filers reported holding TESARO INC in Q4 2015. The put-call ratio across all filers is 1.82 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,501,000 | +132.7% | 20,218 | +22.4% | 0.00% | – |
Q3 2018 | $645,000 | -12.2% | 16,520 | 0.0% | 0.00% | -100.0% |
Q2 2018 | $735,000 | -70.5% | 16,520 | -62.2% | 0.00% | -50.0% |
Q1 2018 | $2,495,000 | -18.9% | 43,656 | +17.5% | 0.00% | 0.0% |
Q4 2017 | $3,077,000 | -37.8% | 37,139 | -3.0% | 0.00% | -50.0% |
Q3 2017 | $4,944,000 | -5.0% | 38,297 | +2.9% | 0.00% | 0.0% |
Q2 2017 | $5,206,000 | +223.8% | 37,218 | +254.5% | 0.00% | +300.0% |
Q1 2017 | $1,608,000 | +12.4% | 10,499 | -1.2% | 0.00% | 0.0% |
Q4 2016 | $1,431,000 | +116.8% | 10,631 | +58.2% | 0.00% | 0.0% |
Q3 2016 | $660,000 | +26.9% | 6,718 | +2.1% | 0.00% | 0.0% |
Q2 2016 | $520,000 | +80.6% | 6,581 | 0.0% | 0.00% | – |
Q1 2016 | $288,000 | +8.7% | 6,581 | +29.9% | 0.00% | – |
Q4 2015 | $265,000 | +31.8% | 5,067 | 0.0% | 0.00% | – |
Q3 2015 | $201,000 | -21.5% | 5,067 | +14.4% | 0.00% | – |
Q2 2015 | $256,000 | +36.2% | 4,431 | +37.4% | 0.00% | – |
Q1 2015 | $188,000 | +67.9% | 3,226 | +7.7% | 0.00% | – |
Q4 2014 | $112,000 | +41.8% | 2,996 | 0.0% | 0.00% | – |
Q3 2014 | $79,000 | – | 2,996 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 2,021,403 | $271,838,000 | 64.82% |
NEA Management Company, LLC | 10,275,113 | $1,381,797,000 | 54.94% |
ORACLE INVESTMENT MANAGEMENT INC | 1,248,086 | $167,843,000 | 27.84% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 89,695 | $12,062,000 | 7.28% |
Perceptive Advisors | 687,993 | $92,521,000 | 6.58% |
Avoro Capital Advisors LLC | 231,700 | $31,159,000 | 6.30% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,500 | $12,705,000 | 5.72% |
Rock Springs Capital Management LP | 613,500 | $82,503,000 | 5.52% |
SENZAR ASSET MANAGEMENT, LLC | 142,300 | $19,136,000 | 5.08% |
BB BIOTECH AG | 974,582 | $131,062,000 | 4.85% |